EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹971 Cr | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr |
What is the latest Profit Before Tax of EMCURE PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹971 Cr |
| Mar2024 | ₹727 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹973 Cr |
| Mar2021 | ₹657 Cr |
How is Profit Before Tax of EMCURE PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹971 Cr | 33.57 | |
| Mar2024 | ₹727 Cr | -2.67 | |
| Mar2023 | ₹747 Cr | -23.17 | |
| Mar2022 | ₹973 Cr | 47.95 | |
| Mar2021 | ₹657 Cr | - | |
Compare Profit Before Tax of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹37,890.7 Cr | 2% | 11.4% | 41.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 2% |
11.4% |
41.6% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses